Kendra Radtke, PharmD PhD, is a clinical pharmacologist specializing in drug development with a focus on optimizing dosing and treatment selection through innovative computational approaches. With a decade of experience in pharmacology research, Kendra has contributed to advancements in translational pharmacology, clinical trial design, and biostatistics, particularly for understudied populations and infectious diseases. In their current role as a Principal Scientist at Genentech, Kendra utilizes electronic health record data to derive real-world evidence on drug safety and effectiveness. Kendra's Ph.D. research significantly influenced new World Health Organization guidelines for tuberculosis prevention and treatment in children.
This person is not in the org chart
This person is not in any teams
This person is not in any offices